SPR Therapeutics

SPRINT PNS System

FDA Clearance of an Expanded Indication for the SPRINT® PNS System Now Enables Treatment in Areas of the Head, Neck, and Torso

–Data from 5,518 Patients were Critical to Achieving the Broader Indication– Cleveland, Ohio- October 19, 2021- SPR Therapeutics® has obtained clearance from the U.S. Food and Drug Administration …
Read moreFDA Clearance of an Expanded Indication for the SPRINT® PNS System Now Enables Treatment in Areas of the Head, Neck, and Torso
Category: Tag: , , , , , ,

SPR Therapeutics Closes $37 Million Growth Equity Financing for Commercial Expansion of its SPRINT® PNS System

– Expanding U.S. Commercial Team Amid Record-Breaking Growth – Cleveland, Ohio- October 18, 2021- SPR Therapeutics, a private medical device company focused on providing patients with pain relief …
Read moreSPR Therapeutics Closes $37 Million Growth Equity Financing for Commercial Expansion of its SPRINT® PNS System
Category: Tag: , , , , ,

Patients Prefer Temporary PNS Treatment for Chronic Back Pain Over RFA and More Invasive Neurostimulation Options Survey Finds

Advances in neurostimulation with improved outcomes and reduced invasiveness have challenged the traditional algorithms for pain management. Traditional pain management algorithms previously favored …
Read morePatients Prefer Temporary PNS Treatment for Chronic Back Pain Over RFA and More Invasive Neurostimulation Options Survey Finds
Category: Tag: , , , , , , , , , ,